Drug Profile
RP 316
Alternative Names: RP-316Latest Information Update: 27 Aug 2007
Price :
$50
*
At a glance
- Originator Bracco
- Class Radiopharmaceutical diagnostics
- Mechanism of Action Single-photon emission-computed tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 27 Aug 2007 Discontinued - Preclinical for Schizophrenia diagnosis in USA (unspecified route)
- 12 Jun 2001 No development reported - Preclinical for Schizophrenia diagnosis in USA (unspecified route)
- 29 Jan 1999 Preclinical development for Schizophrenia diagnosis in USA (unspecified route)